000 | 01629 a2200493 4500 | ||
---|---|---|---|
005 | 20250513231935.0 | ||
264 | 0 | _c20010315 | |
008 | 200103s 0 0 eng d | ||
022 | _a0012-186X | ||
024 | 7 |
_a10.1007/s001250051587 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aForbes, J M | |
245 | 0 | 0 |
_aRenoprotective effects of a novel inhibitor of advanced glycation. _h[electronic resource] |
260 |
_bDiabetologia _cJan 2001 |
||
300 |
_a108-14 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aCross-Linking Reagents |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xcomplications |
650 | 0 | 4 |
_aDiabetic Nephropathies _xprevention & control |
650 | 0 | 4 | _aEnzyme Inhibitors |
650 | 0 | 4 | _aGlomerular Filtration Rate |
650 | 0 | 4 |
_aGlycation End Products, Advanced _xanalysis |
650 | 0 | 4 |
_aGuanidines _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aKidney _xchemistry |
650 | 0 | 4 |
_aKidney Glomerulus _xchemistry |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aSerum Albumin, Bovine |
700 | 1 | _aSoulis, T | |
700 | 1 | _aThallas, V | |
700 | 1 | _aPanagiotopoulos, S | |
700 | 1 | _aLong, D M | |
700 | 1 | _aVasan, S | |
700 | 1 | _aWagle, D | |
700 | 1 | _aJerums, G | |
700 | 1 | _aCooper, M E | |
773 | 0 |
_tDiabetologia _gvol. 44 _gno. 1 _gp. 108-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s001250051587 _zAvailable from publisher's website |
999 |
_c11144418 _d11144418 |